Clinical Trial Update: Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial evaluating ex vivo cultured adult allogeneic mesenchymal stem cells for ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Stempeucel (mesenchymal stromal cells)

Snippet

Sponsor: Stempeutics Research Pvt Ltd | Conditions: Stroke | Phase 1, Phase 2 | Status: WITHDRAWN